TITLE

Stem Cell Mutations Explored

AUTHOR(S)
Luntz, Stephen
PUB. DATE
March 2012
SOURCE
Australasian Science;Mar2012, Vol. 33 Issue 2, p5
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses a research study on pluripotent stem cells which found that there are higher mutation rates in the induced pluripotent stem cell (iPS) lines as compared with the human embryonic stem (HES) cell lines.
ACCESSION #
71615176

 

Related Articles

  • Constraining the Pluripotent Fate of Human Embryonic Stem Cells for Tissue Engineering and Cell Therapy -- The Turning Point of Cell-Based Regenerative Medicine. Parsons, Xuejun H. // British Biotechnology Journal;Oct-Dec2013, Vol. 3 Issue 4, p424 

    To date, the lack of a clinically-suitable source of engraftable human stem/progenitor cells with adequate neurogenic potential has been the major setback in developing safe and effective cell-based therapies for regenerating the damaged or lost CNS structure and circuitry in a wide range of...

  • Pushing the Reset Button: Chemical-Induced Conversion of Amniotic Fluid Stem Cells Into a Pluripotent State. Diecke, Sebastian; Wu, Joseph C // Molecular Therapy;Oct2012, Vol. 20 Issue 10, p1839 

    The authors discuss the study on the factor-free derivation of a pluripotent cell type using a c-Kit+ subpopulation of human amniotic fluid cells. The authors say that the potential of human embryonic stem cells (hESC) to differentiate into any cell type of the human body has raised the hope on...

  • Screening of human pluripotent stem cells using CGH and FISH reveals low-grade mosaic aneuploidy and a recurrent amplification of chromosome 1q. Dekel-Naftali, Michal; Aviram-Goldring, Ayala; Litmanovitch, Talia; Shamash, Jana; Reznik-Wolf, Haike; Laevsky, Ilana; Amit, Michal; Itskovitz-Eldor, Joseph; Yung, Yuval; Hourvitz, Ariel; Schiff, Eyal; Rienstein, Shlomit // European Journal of Human Genetics;Dec2012, Vol. 20 Issue 12, p1248 

    Pluripotency and proliferative capacity of human embryonic stem cells (hESCs) make them a promising source for basic and applied research as well as in therapeutic medicine. The introduction of human induced pluripotent cells (hiPSCs) holds great promise for patient-tailored regenerative...

  • PIEZO2 is required for mechanotransduction in human stem cell-derived touch receptors. Schrenk-Siemens, Katrin; Wende, Hagen; Prato, Vincenzo; Song, Kun; Rostock, Charlotte; Loewer, Alexander; Utikal, Jochen; Lewin, Gary R; Lechner, Stefan G; Siemens, Jan // Nature Neuroscience;Jan2015, Vol. 18 Issue 1, p10 

    Human sensory neurons are inaccessible for functional examination, and thus little is known about the mechanisms mediating touch sensation in humans. Here we demonstrate that the mechanosensitivity of human embryonic stem (hES) cell-derived touch receptors depends on PIEZO2. To recapitulate...

  • Gene Reprogramming Has Become Possible.  // USA Today Magazine;Oct2011, Vol. 140 Issue 2797, p7 

    The article focuses on a study by scientists from the Morganridge Institute for Research at the University of Wisconsin which shows that potentially cancer-causing mutations in induced pluripotent stem cells (IPSCs) do not exhibit substantial increases during gene reprogramming.

  • Induction of tissue-specific stem cells by reprogramming factors, and tissue-specific selection. Noguchi, H; Saitoh, I; Tsugata, T; Kataoka, H; Watanabe, M; Noguchi, Y // Cell Death & Differentiation;Jan2015, Vol. 22 Issue 1, p145 

    Although induced pluripotent stem (iPS) cells have significant implications for overcoming most of the ethical issues associated with embryonic stem (ES) cells, there are still several unresolved issues related to the use of iPS cells for clinical applications, such as teratoma formation. In...

  • Pluripotent Stem cell mirNAs and Metastasis in invasive Breast cancer. Volinia, Stefano; Nuovo, Gerard; Drusco, Alessandra; Costinean, Stefan; Abujarour, Ramzey; Desponts, Caroline; Garofalo, Michela; Baffa, Raffaele; Aeqilan, Rami; Maharry, Kati; Sana Ramiro, Maria Elena; Garzon; Di Leva, Gianpiero; Gasparini, Pierluigi; Dama, Paola; Marchesini, Jlenia; Galasso, Marco; Manfrini, Marco; Zerbinati, Carlotta; Corrà, Fabio // JNCI: Journal of the National Cancer Institute;12/10/2014, Vol. 106 Issue 12, p1 

    Background The purpose of this study is to determine whether microRNA for pluripotent stem cells are also expressed in breast cancer and are associated with metastasis and outcome. Methods We studied global microRNA profiles during differentiation of human embryonic stem cells (n =26) and in...

  • Targeted Genomic Integration of a Selectable Floxed Dual Fluorescence Reporter in Human Embryonic Stem Cells. Gantz, Jay A.; Palpant, Nathan J.; Welikson, Robert E.; Hauschka, Stephen D.; Murry, Charles E.; Laflamme, Michael A. // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    The differentiation of pluripotent stem cells involves transition through a series of specific cell states. To understand these cell fate decisions, the field needs improved genetic tools for the labeling, lineage tracing and selection of specific cell types from heterogeneous differentiating...

  • Small Molecule Screening with Laser Cytometry Can Be Used to Identify Pro-Survival Molecules in Human Embryonic Stem Cells. Sherman, Sean P.; Pyle, April D. // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Differentiated cells from human embryonic stem cells (hESCs) provide an unlimited source of cells for use in regenerative medicine. The recent derivation of human induced pluripotent cells (hiPSCs) provides a potential supply of pluripotent cells that avoid immune rejection and could provide...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics